FDA Logo links to FDA home pageSkip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
 

CDER 2007 Meeting Documents


Anesthetic and Life Support Drugs Advisory Committee

Executive Secretary: Vicky Ferretti-Aceto, Pharm.D., R.Ph., (HFD-21), (301) 827-7001

March 29, 2007

  • Notice of Meeting (txt) (pdf)
  • There are no Nature and Basis Statements of Conflict(s) of Interest
  • Draft Agenda (pdf)
  • Revised Committee Roster (pdf)
  • Revised Meeting Roster (pdf)
  • Roster (pdf)
  • Briefing Information (htm)
  • Slides (htm)
  • Minutes (pdf)
  • Transcript (rtf) (pdf), Concordance Index (pdf)

[Top]

Anti-Infective Drugs Advisory Committee

Executive Secretary: LT Sohail Mosaddegh, Pharm.D., R.Ph., (HFD-21), (301) 827-7001

April 12, 2007 Joint Meeting with Pediatric Advisory Committee

  • Notice of Meeting (txt) (pdf)
  • There are no Nature and Basis Statements of Conflict(s) of Interest
  • Final Agenda (pdf)
  • Draft Agenda (pdf)
  • Final Meeting Roster (pdf)
  • Anti-Infective Drugs AC Roster (pdf)
  • Draft Meeting Roster (pdf)
  • Pediatric AC Roster (pdf)
  • Briefing Information (htm)
  • Final Questions (pdf)
  • Draft Questions (pdf)
  • Slides (htm)
  • Transcript: Part1.pdf, Part 2, pdf, Part 3.pdf, Part 4.pdf
  • Minutes (pdf)

April 11, 2007

[Top]

Antiviral Drugs Advisory Committee

Executive Secretary: Cicely Reese, Pharm.D., (HFD-21), (301) 827-7001

September 5, 2007

  • Notice of Meeting [TXT] [PDF] [PRE-PUB]
  • No Waivers for Conflicts of Interest
  • Final Agenda for September 5, 2007 (pdf)
  • Draft Agenda for September 5, 2007 Meeting (pdf)
  • Final Meeting Roster for September 5, 2007 (pdf)
  • Roster for September 5, 2007 Meetings: Draft Meeting (pdf), Committee (pdf)
  • Final Questions for September 5, 2007 Meeting (pdf)
  • Draft Questions for September 5, 2007 Meeting (pdf)
  • Briefing Information for September 5, 2007 Meeting (htm)
  • Slides for September 5, 2007 (htm)
  • Transcript: (Part1.pdf), (Part2.pdf), (Part3.pdf)

April 24, 2007

  • Notice of Meeting  (txt) (pdf)
  • Nature and Basis Statements of Conflict(s) of Interest for April 24, 2007 (htm)
  • Change in Meeting Location for April 24, 2007 Meeting (pdf)
  • Final Agenda (pdf)
  • Draft Agenda (pdf)
  • Final Roster of Voting Committee Members (pdf)
  • Rosters : Committee (pdf), Meeting (pdf)
  • Briefing Information (htm)
  • Final Report (pdf)
  • Final Questions for April 24, 2007 Meeting (pdf) (ppt) (htm)
  • Slides (htm)
  • Minutes (pdf)
  • Transcript (Part1.pdf) (Part2.pdf) (Part3.pdf) (Part4.pdf) (Index.pdf)

[Top]

Arthritis Drug Advisory Committee

Executive Secretary: Niclole Vesely, Pharm. D., RPL (HFD-21), (301) 827-7001

April 12, 2007

[Top]

Cardiovascular & Renal Drugs Advisory Committee

Executive Secretary: Cathy A. Miller, MPH, RN, (HFD-21), (301) 827-7001

December 11 and 12, 2007

  • Notice of Meeting [TXT] [PDF] [PRE-PUB]
  • Waivers for Conflicts of Interest for December 11-12, 2007 Meeting (htm)
  • Draft Agenda for December 11 & 12, 2007 (pdf)
  • Roster for December 11, 2007 (pdf)
  • Final Roster for December 11, 2007 (pdf)
  • Roster for December 12, 2007 (pdf)
  • Final Roster for December 12, 2007 (pdf)
  • Briefing Information for December 11, 2007 (htm)
  • Briefing Information for December 12, 2007 (htm)
  • Questions for December 11, 2007: Part1.pdf, Part2.pdf
  • Final Questions for December 11, 2007: Part1Final.pdf, Part2Final.pdf
  • Questions for December 12, 2007 (pdf)
  • Final Questions for December 12, 2007 (SS)
  • Slides for December 11, 2007 (htm)
  • Slides for December 12, 2007 (htm)
  • Minutes for December 11, 2007 (pdf)
  • Minutes for December 12, 2007 (pdf)
  • Transcript for December 11, 2007 Meeting: Index (pdf), Part1 (pdf), Part2 (pdf), Part3 (pdf), Part4 (pdf), Part5 (pdf)
  • Transcript for December 12, 2007 Meeting: Index (pdf), Part1 (pdf), Part2 (pdf), Part3 (pdf), Part4 (pdf), Part5 (pdf)

October 16, 2007

September 12, 2007 Joint Meeting with the Drug Safety and Risk Management Advisory Committee

September 11, 2007 Joint Meeting with the Drug Safety and Risk Management Advisory Committee

April 18, 2007

[Top]

Dermatologic and Ophthalmic Drugs Advisory Committee

Executive Secretary: LT Sohail Mosaddeh, Pharm.D., R.Ph., (HFD-21), (301) 827-7001

August 1, 2007 Joint Meeting with the Drug Safety and Risk Management Advisory Committee

  • Notice of Meeting  [TXT] [PDF] [PRE-PUB]
  • Nature and Basis Statements of Conflict(s) of Interest (htm)
  • Final Agenda (pdf)
  • Agenda (pdf)
  • Final Meeting Roster (pdf)
  • Rosters: Meeting (pdf), DODAC Committee (pdf), DSARM Committee (pdf)
  • Briefing Information (htm) (Updated 9/7/07- added Addendum)
  • Final Questions (pdf)
  • Slides (htm)
  • Transcript (Part1.pdf), (Part2.pdf), (Part3.pdf)

[Top]

Drug Safety and Risk Management Advisory Committee

Executive Secretary: Vicky Ferretti-Aceto, PharmD, R.Ph. (HFD-21), (301) 827-7001

September 12, 2007 Joint Meeting with the Cardiovascular & Renal Drugs Advisory Committee

September 11, 2007 Joint Meeting with the Cardiovascular & Renal Drugs Advisory Committee

August 1, 2007 Joint Meeting with the Dermatologic and Ophthalmic Drugs Advisory Committee

July 31, 2007 Joint Meeting with the Gastrointestinal Drugs Advisory Committee

July 30, 2007 Joint Meeting with the Endocrinologic and Metabolic Drugs Advisory Committee

[Top]

Endocrinologic and Metabolic Drugs Advisory Committee

Executive Secretary: Cathy A. Miller, MPH, RN, (HFD-21), (301) 827-7001

December 13, 2007 Joint Meeting with the Nonprescription Drugs Advisory Committee

  • Notice of Meeting [TXT] [PDF] [PRE-PUB]
  • Waivers for Conflicts of Interest for December 13, 2007 Meeting (htm)
  • Agenda (pdf)
  • Final Agenda (pdf)
  • Rosters: EMDAC Committee (pdf), NDAC Committee (pdf), Meeting (pdf)
  • Final Roster (pdf)
  • Briefing Information (htm)
  • Draft Questions (pdf)
  • Final Questions (pdf)
  • Slides (htm)
  • Final Minutes (pdf)
  • Transcript: Index (pdf), Part1 (pdf), Part2 (pdf), Part3 (pdf), Part4 (pdf)

July 30, 2007 Joint Meeting with the Drug Safety and Risk Management Advisory Committee

June 13, 2007

  • Notice of Meeting (pdf) (htm)
  • No Waivers for Conflicts of Interest
  • Draft Agenda (pdf)
  • Draft Meeting Roster (pdf)
  • Draft Committee Roster (pdf)
  • Briefing Information (htm)
  • ERRATA to Briefing Information for June 13, 2007 Meeting (pdf)
  • Final Questions (ppt) (htm)
  • Draft Questions (pdf)
  • Slides for June 13, 2007 Meeting (htm)
  • Final Minutes (pdf)
  • Transcript: (Index.pdf), (Part1.pdf), (Part2.pdf), (Part3.pdf), (Part4.pdf)

[Top]

Gastrointestinal Drugs Advisory Committee

Executive Secretary: Vicky Ferretti-Aceto, PharmD, R.Ph. (HFD-21), (301) 827-7001

July 31, 2007 Joint Meeting with the Drug Safety and Risk Management Advisory Committee

[Top]

Nonprescription Drugs Advisory Committee

Executive Secretary: LT Darrell Lyons, BSN, RN, (HFD-21), (301) 827-7001

December 14, 2007

  • Notice of Meeting [TXT] [PDF] [PRE-PUB]
  • Waivers for Conflicts of Interest (htm)
  • Agenda (pdf)
  • Final Agenda (pdf)
  • Rosters: Committee (pdf), Meeting (pdf)
  • Final NDAC Members Roster (pdf)
  • Briefing Information (htm)
  • Draft Questions (pdf)
  • Final Questions (pdf)
  • Slides (htm)
  • Transcript: Part1 (pdf), Part2 (pdf), Part3 (pdf), Part4 (pdf)
  • Minutes (pdf)

December 13, 2007 Joint Meeting with the Endocrinologic and Metabolic Drugs Advisory Committee

  • Notice of Meeting [TXT] [PDF] [PRE-PUB]
  • Waivers for Conflicts of Interest for December 13, 2007 Meeting (htm)
  • Agenda (pdf)
  • Final Agenda (pdf)
  • Rosters: EMDAC Committee (pdf), NDAC Committee (pdf), Meeting (pdf)
  • Final Roster (pdf)
  • Briefing Information (htm)
  • Draft Questions (pdf)
  • Final Questions (pdf)
  • Slides (htm)
  • Final Minutes (pdf)
  • Transcript: Index (pdf), Part1 (pdf), Part2 (pdf), Part3 (pdf), Part4 (pdf)

October 18 & 19, 2007 Joint Meeting with the Pediatric Advisory Committee

  • Notice of Meeting [TXT] [PDF] [PRE-PUB]
  • Amendment of Notice [TXT] [PDF] [PRE-PUB]
  • Updated Waivers for Conflicts of Interest for October 18 & 19, 2007 Meeting (htm)
  • Posted Nature and Basis Statements of Conflict(s) of Interest for October 18-19, 2007 Meeting (htm)
  • Draft Agenda (pdf)
  • Final Agenda (pdf)
  • Rosters for October 18 & 19, 2007: Meeting (pdf), Committee (pdf)
  • Final Rosters for October 18 & 19, 2007: Meeting (pdf), Committee (pdf)
  • Questions: (pdf)
  • Briefing Information for October 18 and 19, 2007 Meeting (htm)
  • Errata to FDA Background document for the advisory committee meeting on October 18 & 19, 2007 (pdf) (htm)
  • Slides for October 18 & 19, 2007 (htm)
  • Final Minutes for October 18 & 19, 2007 (pdf)
  • Transcript for October 18 & 19, 2007: (Part1.pdf), (Part2.pdf), (Part3.pdf), (Part4.pdf)

[Top]

Oncologic Drugs Advisory Committee

Executive Secretary: Niclole Vesely, Pharm. D., RPL (HFD-21), (301) 827-7001

December 5, 2007

  • Notice of Meeting [TXT] [PDF] [PRE-PUB]
  • Waivers for Conflicts of Interest (htm)
  • Final Agenda (pdf)
  • Members Roster (pdf)
  • Committee Roster (pdf)
  • Briefing for December 5, 2007 Meeting (htm)
  • Final Questions (ppt) (htm)
  • Slides (htm)
  • Final Minutes (pdf)
  • Transcript: Part1(pdf), Part2 (pdf), Part3 (pdf)

July 24, 2007

June 27, 2007 Pediatric Subcommittee

May 9-10, 2007

[Top]

Peripheral and Central Nervous System Drugs Advisory Committee

Executive Secretary: LT Darrell Lyons, BSN, RN, (HFD-21), 301 827-7001

December 6, 2007

[Top]

Pharmaceutical Science and Clinical Pharmacology Advisory Committee (Formerly Advisory Committee for Pharmaceutical Science)

Executive Secretary: Mimi Phan, Pharm.D., (HFD-21), (301) 827-7001

  • Change of Name and Function [TXT] [PDF]

May 1-2, 2007

Manufacturing Subcommittee

April 30, 2007

  • Notice of Meeting (txt) (pdf)
  • Cancellation of Meeting (txt) (pdf )

[Top]

 

Psychopharmacologic Drugs Advisory Committee

Executive Secretary: Cicely Reese, Pharm.D., (HFD-21), (301) 827-7001

[Top]

Pulmonary-Allergy Drugs Advisory Committee

Executive Secretary: Teresa Watkins, R.Ph., (HFD-21), (301) 827-7001

May 1, 2007

[Top]

Reproductive Health Drugs Advisory Committee

Executive Secretary: Teresa Watkins, R.Ph., (HFD-21), (301) 827-7001

January 23-24, 2007

  • Notice of Meeting ( txt) (pdf)
  • Nature and Basis Statements of Conflict(s) of Interest (htm)
  • Agends for January 23, 2007 Meeting: Draft (pdf), Final (pdf)
  • Agends for January 24, 2007 Meeting: Draft (pdf), Final (pdf)
  • Rosters: Committee (pdf), Draft (pdf), Final (pdf)
  • Questions for January 23, 2007 (htm)
  • Questions for January 24, 2007 (htm)
  • Briefing Information for January 23-24, 2007 (htm)
  • Slides for January 23, 2007 (htm)
  • Slides for: January 24, 2007 (htm)
  • Minutes for January 23-24, 2007 (pdf)
  • Index for January 23, 2007 Transcript (pdf)
  • Transcript for January 23, 2007 (pdf)
  • Index for January 24, 2007 Transcript (pdf)
  • Transcript for January 24, 2007 (pdf)

[Top


Top | Up | AC Home Page

Page last updated: February 25, 2008